nRichDX will continue its Current Perspectives in Liquid Biopsy webinar series on April 12, 2023, with a webinar from Dr. Klaus Pantel titled, "Current Perspectives on Liquid Biopsy Technologies".
Dr. Pantel is Chairman of the Institute of Tumour Biology University Medical Center Hamburg-Eppendorf and Founder and Chairman of the European Liquid Biopsy Society (ELBS). Dr. Pantel is a recognized leader in the liquid biopsy community. Dr. Pantel is also a member of the nRichDX Scientific Advisory Board.
The live webinar will take place on April 12 2023 at 9 am PT / 12 Noon ET / 6 pm CET. The webinar will feature a keynote presentation from Dr. Pantel as well as a short presentation from Dr. Nafiseh Jafari, Director of R&D for nRichDX.
Those wishing to attend the live event or receive a link to the recorded webinar should register to attend at this link.
nRichDX® Inc, based in California, is an emerging leader in liquid-based assay sample prep solutions that enable customers to extract much more analysis-ready target as compared to existing methods. The company’s patented Revolution™ Sample Prep System is the first and only high-yield, IVD-labeled liquid biopsy sample prep platform that can process a wide range of total volumes from 1 mL - 50 mL in a single magnetic bead-based extraction, without the yield-lowering pooling, transfer, or concentration steps other methods require. nRichDX solves one of precision medicine’s greatest problems – – inaccurate or failed assays due to a lack of target material. The Revolution System greatly enhances test sensitivity and enables testing for earlier detection, monitoring, timely treatment, and optimal patient outcomes. More information at www.nrichdx.com